Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Latest reported GLUE revenue for 2025-12-31 was $123.7M. Net income was -$38.6M. GLUE currently screens at market cap $1.56B.
Use this GLUE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the GLUE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the GLUE SEC filings page. Lician reads the product cache first so this HTML stays unique to Monte Rosa Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full GLUE income, balance, and cash tables.